Literature DB >> 26141962

Family Communication and Genetic Counseling: The Case of Hereditary Breast and Ovarian Cancer.

J Green1, M Richards, F Murton, H Statham, N Hallowell.   

Abstract

In familial breast/ovarian cancer, the information that the proband is able to supply about other family members is of critical importance for genetic counseling. This frequently requires family communication. Forty-six women attending a cancer genetics clinic were interviewed as part of a longitudinal study. Nearly all reported affected maternal, rather than paternal relatives, which may indicate lack of awareness by women with paternal histories. There was also much more communication among female relatives. Mothers, where they were still alive, were key figures in supplying family information. Although the majority of the sample contacted at least one relative regarding counseling, most named a relative with whom they did not feel able to communicate on this subject. Probands balanced the perceived obligation of passing on information with that of not causing alarm. Communication, both obtaining and giving information, was impeded by adoption, divorce and remarriage, family rifts, and large age gaps between siblings.

Entities:  

Year:  1997        PMID: 26141962     DOI: 10.1023/A:1025611818643

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  11 in total

1.  The transfer of information about genetic transmission to brothers and sisters of parents with a CF-child.

Authors:  L Denayer; K De Boeck; G Evers-Kiebooms; H Van den Berghe
Journal:  Birth Defects Orig Artic Ser       Date:  1992

2.  Diffusion of information about genetic risk within families.

Authors:  Ségolène Ayme; Geneviève Macquart-Moulin; Claire Julian-Reynier; Françoise Chabal; Francis Giraud
Journal:  Neuromuscul Disord       Date:  1993 Sep-Nov       Impact factor: 4.296

3.  Counseling families with hereditary breast and ovarian cancer: A psychosocial perspective.

Authors:  M P Richards; N Hallowell; J M Green; F Murton; H Statham
Journal:  J Genet Couns       Date:  1995-09       Impact factor: 2.537

4.  Systemically-Based Psychotherapeutic Techniques in Genetic Counseling.

Authors:  D L Eunpu
Journal:  J Genet Couns       Date:  1997-03       Impact factor: 2.537

5.  Genetic counseling in families with inherited balanced translocations: experience with 36 families.

Authors:  G Wolff; E Back; S Arleth; U Rapp-Körner
Journal:  Clin Genet       Date:  1989-06       Impact factor: 4.438

6.  Transmitting balanced translocation carrier information within families: a follow-up study.

Authors:  L Suslak; D M Price; F Desposito
Journal:  Am J Med Genet       Date:  1985-02

7.  Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research.

Authors:  C Pope; N Mays
Journal:  BMJ       Date:  1995-07-01

8.  Psychosocial issues raised by a familial ovarian cancer register.

Authors:  J Green; F Murton; H Statham
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

9.  Social system responses to Huntington disease.

Authors:  S Kessler; M Bloch
Journal:  Fam Process       Date:  1989-03

10.  Invited essay on the psychological aspects of genetic counseling. V. Preselection: a family coping strategy in Huntington disease.

Authors:  S Kessler
Journal:  Am J Med Genet       Date:  1988-11
View more
  49 in total

Review 1.  Communicating genetic risk information within families: a review.

Authors:  Mel Wiseman; Caroline Dancyger; Susan Michie
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers.

Authors:  Nina Strømsvik; Målfrid Råheim; Nina Oyen; Lars Fredrik Engebretsen; Eva Gjengedal
Journal:  J Genet Couns       Date:  2010-03-20       Impact factor: 2.537

Review 3.  Evolution of the colored eco-genetic relationship map (CEGRM) for assessing social functioning in women in hereditary breast-ovarian (HBOC) families.

Authors:  June A Peters; Lindsey Hoskins; Sheila Prindiville; Regina Kenen; Mark H Greene
Journal:  J Genet Couns       Date:  2006-11-17       Impact factor: 2.537

4.  Facilitating family communication about predictive genetic testing: probands' perceptions.

Authors:  Clara L Gaff; Veronica Collins; Tiffany Symes; Jane Halliday
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

Review 5.  Illness representations, self-regulation, and genetic counseling: a theoretical review.

Authors:  Shoshana Shiloh
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

6.  Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.

Authors:  C Phelps; F Wood; P Bennett; K Brain; J Gray
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.537

7.  An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.

Authors:  Paboda Ratnayake; Claire E Wakefield; Bettina Meiser; Graeme Suthers; Melanie A Price; Jessica Duffy; Kathy Tucker
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

8.  Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.

Authors:  Kenneth P Tercyak; Tiffani A Demarco; Bryn D Mars; Beth N Peshkin
Journal:  Am J Med Genet A       Date:  2004-11-15       Impact factor: 2.802

9.  Women's perceptions of the personal and family impact of genetic cancer risk assessment: focus group findings.

Authors:  Deborah J MacDonald; Linda Sarna; Jeffrey N Weitzel; Betty Ferrell
Journal:  J Genet Couns       Date:  2009-11-10       Impact factor: 2.537

10.  Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.

Authors:  Susan V Montgomery; Andrea M Barsevick; Brian L Egleston; Ruth Bingler; Karen Ruth; Suzanne M Miller; John Malick; Terrence P Cescon; Mary B Daly
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.